/PPTDF
PPTDF Stock - PeptiDream Inc.
Healthcare|BiotechnologyOTC
$12.80+0.00%
+$0.00 (+0.00%) • Dec 19
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.69
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $14.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PPTDF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$12.67 – $12.93
TARGET (TP)$14.72
STOP LOSS$11.78
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.05
52W High$17.85
52W Low$9.61
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $46.68B | $26.85B | $9.37B | $11.68B | $7.22B |
| Gross Profit | $34.50B | $18.11B | $7.01B | $9.53B | $5.57B |
| Gross Margin | 73.9% | 67.5% | 74.8% | 81.6% | 77.1% |
| Operating Income | $21.11B | $8.98B | $4.42B | $6.99B | $3.58B |
| Net Income | $15.01B | $7.55B | $3.61B | $4.45B | $2.77B |
| Net Margin | 32.2% | 28.1% | 38.5% | 38.1% | 38.4% |
| EPS | $115.85 | $58.19 | $19.96 | $35.40 | $22.42 |
Company Overview
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PPTDFBeat Rate
19%
Last 16 quarters
Avg Surprise
-107.4%
EPS vs Estimate
Beats / Misses
3/13
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q1 24
-255.1%
$-0.03vs$0.02
Q2 24
-141.5%
$-0.04vs$0.10
Q3 24
-2.1%
$0.90vs$0.92
Q4 24
-176.2%
$-0.02vs$0.02
Q1 25
-126.3%
$-0.13vs$-0.06
Q2 25
-74.4%
$-0.05vs$-0.03
Q3 25
-182.8%
$-0.06vs$0.07
Q4 25
+99.3%
$-0.00vs$-0.05
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 16, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.05 | $-0.00 | +99.3% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $0.07 | $-0.06 | -182.8% | ✗ MISS |
Q2 2025 | May 13, 2025 | $-0.03 | $-0.05 | -74.4% | ✗ MISS |
Q1 2025 | Feb 13, 2025 | $-0.06 | $-0.13 | -126.3% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $0.02 | $-0.02 | -176.2% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $0.92 | $0.90 | -2.1% | ✗ MISS |
Q2 2024 | May 14, 2024 | $0.10 | $-0.04 | -141.5% | ✗ MISS |
Q1 2024 | Feb 14, 2024 | $0.02 | $-0.03 | -255.1% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $0.19 | $0.22 | +16.7% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.01 | $-0.03 | -278.6% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.00 | $-0.01 | -317.9% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $0.30 | $0.46 | +52.0% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $0.09 | $0.05 | -44.7% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | $0.21 | $0.01 | -94.1% | ✗ MISS |
Q2 2022 | May 12, 2022 | $0.18 | $-0.05 | -129.0% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | $0.04 | $0.02 | -63.8% | ✗ MISS |
Q3 2021 | Sep 30, 2021 | — | $0.17 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.02 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PPTDF
What is PPTDF's current stock price?
PeptiDream Inc. (PPTDF) is currently trading at $12.80 per share. The stock has moved +0.00% today.
What is the analyst price target for PPTDF?
No analyst price targets are currently available for this stock.
What sector is PeptiDream Inc. in?
PeptiDream Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is PPTDF's market cap?
PeptiDream Inc. has a market capitalization of $1.65 billion, making it a small-cap company.
Does PPTDF pay dividends?
No, PeptiDream Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCSBTF
Kuros Biosciences AG
$38.34
Mkt Cap: $1.5B
CSPHF
CStone Pharmaceuticals
$0.89
Mkt Cap: $1.3B
GENSF
Genus plc
$35.15
Mkt Cap: $2.3B
MEOBF
Mesoblast Limited
$1.35
Mkt Cap: $1.7B
NURPF
Neuren Pharmaceuticals Limited
$12.88
Mkt Cap: $1.6B
ONTTF
Oxford Nanopore Technologies plc
$1.72
Mkt Cap: $1.7B
PHMMF
Pharma Mar, S.A.
$86.26
Mkt Cap: $1.5B
SAEYY
Redcare Pharmacy N.V.
$7.50
Mkt Cap: $1.5B
SHPPF
Redcare Pharmacy N.V.
$75.00
Mkt Cap: $1.5B
SNBIF
SanBio Company Limited
$16.45
Mkt Cap: $1.2B
Explore stocks similar to PPTDF for comparison